Cyclosporine-induced autologous graft versus host disease: assessment of cytolytic effector mechanisms and the V beta T-cell receptor repertoire.
Ruvolo
P
P
Johns Hopkins Bone Marrow Transplant Unit, Baltimore, Maryland.
Bright
E
E
Kennedy
M J
MJ
Morris
L
L
Fischer
A
A
Vogelsang
G
G
Jones
R
R
Hess
A
A
D015703:Antigens, CD / Q000032:analysis; D016026:Bone Marrow Transplantation / Q000276:immunology*; D001943:Breast Neoplasms / Q000628:therapy; D016572:Cyclosporine / Q000009:adverse effects*; D003602:Cytotoxicity, Immunologic; D015870:Gene Expression; D006086:Graft vs Host Disease / Q000139:chemically induced*; D006681:HLA-D Antigens / Q000276:immunology; D015395:Histocompatibility Antigens Class I / Q000276:immunology; D006801:Humans; D016130:Immunophenotyping; D007694:Killer Cells, Natural / Q000276:immunology; D015470:Leukemia, Myeloid, Acute / Q000628:therapy; D008213:Lymphocyte Activation; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy; D016133:Polymerase Chain Reaction; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000235:genetics / Q000276:immunology*; D016692:Receptors, Antigen, T-Cell, gamma-delta / Q000276:immunology; D012867:Skin / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*; D014182:Transplantation, Autologous
D015703:Antigens, CD; D006681:HLA-D Antigens; D015395:Histocompatibility Antigens Class I; D016693:Receptors, Antigen, T-Cell, alpha-beta; D016692:Receptors, Antigen, T-Cell, gamma-delta; D016572:Cyclosporine